These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 18457385)

  • 1. Recent developments in fragment-based drug discovery.
    Congreve M; Chessari G; Tisi D; Woodhead AJ
    J Med Chem; 2008 Jul; 51(13):3661-80. PubMed ID: 18457385
    [No Abstract]   [Full Text] [Related]  

  • 2. Structural genomics and drug discovery: all in the family.
    Weigelt J; McBroom-Cerajewski LD; Schapira M; Zhao Y; Arrowsmith CH
    Curr Opin Chem Biol; 2008 Feb; 12(1):32-9. PubMed ID: 18282486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for transient biological interactions as applied to albumin ligands: a new concept for drug discovery.
    Ohlson S; Shoravi S; Fex T; Isaksson R
    Anal Biochem; 2006 Dec; 359(1):120-3. PubMed ID: 17052679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using NMR for ligand discovery and optimization.
    Villar HO; Yan J; Hansen MR
    Curr Opin Chem Biol; 2004 Aug; 8(4):387-91. PubMed ID: 15288248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fragment-based screening using X-ray crystallography and NMR spectroscopy.
    Jhoti H; Cleasby A; Verdonk M; Williams G
    Curr Opin Chem Biol; 2007 Oct; 11(5):485-93. PubMed ID: 17851109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systems biology and systems chemistry: new directions for drug discovery.
    Brown JB; Okuno Y
    Chem Biol; 2012 Jan; 19(1):23-8. PubMed ID: 22284351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The modular approach to ligand discovery.
    Karan C; Tallarico JA
    Chem Biol; 2004 Mar; 11(3):292-3. PubMed ID: 15123257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Redefining priorities in gene-based drug discovery.
    Khodadoust MM; Klein TP
    Nat Biotechnol; 2001 Aug; 19(8):707. PubMed ID: 11479549
    [No Abstract]   [Full Text] [Related]  

  • 9. Virtual Discovery Europe--Select Biosciences Conference. Computer-aided drug design and screening.
    Kubinyi H
    IDrugs; 2007 Dec; 10(12):869-73. PubMed ID: 18041683
    [No Abstract]   [Full Text] [Related]  

  • 10. Fragment-based ligand discovery.
    Fischer M; Hubbard RE
    Mol Interv; 2009 Feb; 9(1):22-30. PubMed ID: 19299661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variation of protein binding cavity volume and ligand volume in protein-ligand complexes.
    Saranya N; Selvaraj S
    Bioorg Med Chem Lett; 2009 Oct; 19(19):5769-72. PubMed ID: 19706358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Discovering high-affinity ligands for proteins: SAR by NMR].
    Kamisuki S; Uesugi M
    Tanpakushitsu Kakusan Koso; 2007 Oct; 52(13 Suppl):1818-9. PubMed ID: 18051441
    [No Abstract]   [Full Text] [Related]  

  • 13. On-chip fragment-based approach for discovery of high-affinity bivalent inhibitors.
    Miyazaki I; Simizu S; Ishida K; Osada H
    Chembiochem; 2009 Mar; 10(5):838-43. PubMed ID: 19226504
    [No Abstract]   [Full Text] [Related]  

  • 14. Ligand mapping on protein surfaces by the 3D-RISM theory: toward computational fragment-based drug design.
    Imai T; Oda K; Kovalenko A; Hirata F; Kidera A
    J Am Chem Soc; 2009 Sep; 131(34):12430-40. PubMed ID: 19655800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Organic protein chemistry: drug discovery through the chemical modification of proteins.
    Rademann J
    Angew Chem Int Ed Engl; 2004 Sep; 43(35):4554-6. PubMed ID: 15317010
    [No Abstract]   [Full Text] [Related]  

  • 16. Recent progress in fragment-based lead discovery.
    Schulz MN; Hubbard RE
    Curr Opin Pharmacol; 2009 Oct; 9(5):615-21. PubMed ID: 19477685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between performance of QM/MM docking and simple classification of binding sites.
    Chung JY; Hah JM; Cho AE
    J Chem Inf Model; 2009 Oct; 49(10):2382-7. PubMed ID: 19799409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and implementation of an ribonucleic acid (RNA) directed fragment library.
    Bodoor K; Boyapati V; Gopu V; Boisdore M; Allam K; Miller J; Treleaven WD; Weldeghiorghis T; Aboul-ela F
    J Med Chem; 2009 Jun; 52(12):3753-61. PubMed ID: 19445516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FieldScreen: virtual screening using molecular fields. Application to the DUD data set.
    Cheeseright TJ; Mackey MD; Melville JL; Vinter JG
    J Chem Inf Model; 2008 Nov; 48(11):2108-17. PubMed ID: 18991371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Form follows function: shape analysis of protein cavities for receptor-based drug design.
    Weisel M; Proschak E; Kriegl JM; Schneider G
    Proteomics; 2009 Jan; 9(2):451-9. PubMed ID: 19142949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.